Business Segments · Research, development and engineering expenses
Orthopaedics — Research, development and engineering expenses
Stryker Orthopaedics — Research, development and engineering expenses increased by 3.9% to $132.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.9%, from $136.00M to $132.00M. Over 2 years (FY 2022 to FY 2024), Orthopaedics — Research, development and engineering expenses shows an upward trend with a 6.4% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ3 2025
Rolls up toR&D
How to read this metric
An increase indicates higher investment in innovation, which may drive future growth but pressures current operating margins.
Detailed definition
These are the costs incurred by the Orthopaedics segment to research, design, and develop new medical devices, implants,...
Peer comparison
Comparable to R&D spending metrics reported by major orthopedic and medical technology competitors.
Metric ID:
syk_segment_orthopaedics_research_development_and_engineering_expensesHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $119.25M | $119.25M | $119.25M | $119.25M | $127.00M | $127.00M | $127.00M | $127.00M | $134.00M | $136.00M | $136.00M | $134.00M | $140.00M | $127.00M | $132.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.5% | +0.0% | +0.0% | +0.0% | +5.5% | +1.5% | +0.0% | -1.5% | +4.5% | -9.3% | +3.9% |
| YoY Change | — | — | — | — | +6.5% | +6.5% | +6.5% | +6.5% | +5.5% | +7.1% | +7.1% | +5.5% | +4.5% | -6.6% | -2.9% |
Range$119.25M – $140.00M
CAGR+2.9%
Avg YoY Growth+4.2%
Median YoY Growth+6.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's orthopaedics — research, development and engineering expenses?
- Stryker (SYK) reported orthopaedics — research, development and engineering expenses of $132.00M in Q3 2025.
- How has Stryker's orthopaedics — research, development and engineering expenses changed year-over-year?
- Stryker's orthopaedics — research, development and engineering expenses decreased by 2.9% year-over-year, from $136.00M to $132.00M.
- What is the long-term trend for Stryker's orthopaedics — research, development and engineering expenses?
- Over 2 years (2022 to 2024), Stryker's orthopaedics — research, development and engineering expenses has grown at a 6.4% compound annual growth rate (CAGR), from $477.00M to $540.00M.
- What does orthopaedics — research, development and engineering expenses mean?
- The amount spent on developing new orthopedic products and technologies.